Apollo Hospitals Declines 0.62% Despite Strong Derivatives Activity and Intraday Rally

10 August 2026: Week Begins with Slight Decline Amid Stable Sensex

Apollo Hospitals opened the week at Rs.8,921, declining by 0.66% from the previous close. The Sensex, in contrast, edged up 0.09% to 37,131.97. Trading volume was moderate at 19,020 shares, signalling cautious investor sentiment. The stock remained above its 100-day and 200-day moving averages, indicating underlying medium-term support despite the early weakness.

11 August 2026: Open Interest Surges 10.07% Despite Price Drop

The stock fell 1.91% to Rs.8,751, marking the second consecutive day of decline. Notably, open interest in derivatives rose sharply by 10.07%, from 34,618 to 38,103 contracts, reflecting heightened market activity. The total derivatives value reached approximately ₹54,187.7 lakhs, with options dominating at ₹57,147.5 crores in notional value. This divergence between rising open interest and falling price suggests increased short selling or protective hedging amid near-peak price levels.

Investor participation intensified, with delivery volumes rising 80.27% compared to the five-day average, indicating genuine accumulation despite short-term price pressure. The stock remained close to its 52-week high of Rs.9,050, underscoring resilience amid volatility.

12 August 2026: Sharp 33.7% Open Interest Increase Amid Continued Price Weakness

Apollo Hospitals experienced a further decline of 2.13%, closing at Rs.8,565, its weekly low. Open interest surged 33.7% to 51,983 contracts, with futures and options values totaling ₹62,220.4 lakhs. The bulk of trading clustered near the day’s low of Rs.8,524.5, signalling either accumulation by contrarian investors or increased short positions.

The hospital sector declined 2.57%, closely mirroring Apollo’s performance, while the Sensex fell 0.63%. Delivery volumes increased 42.63%, reinforcing investor conviction despite the correction. The stock traded below its 5-day, 20-day, and 50-day moving averages but remained above longer-term averages, indicating a mixed technical picture.

13 August 2026: Positive Quarterly Results and Mojo Upgrade Support Price Recovery

Following the release of very positive quarterly financials, Apollo Hospitals’ mojo grade was upgraded from Hold to Buy, reflecting record revenues of ₹7,043.50 crores and net profit of ₹580.70 crores for Q1 FY2027. The operating profit margin expanded to 15.51%, and ROCE improved to 17.41%, underscoring operational strength.

The stock rebounded modestly by 0.35% to Rs.8,595 on robust trading volumes of 33,602 shares. Open interest rose 12.3% to 60,893 contracts, signalling renewed market optimism. Institutional participation was strong, with delivery volumes surging 126.06% to 5.46 lakh shares, indicating accumulation ahead of expected growth.

Technically, the stock remained above its 100-day and 200-day moving averages, though short-term averages continued to act as resistance. The mixed technical momentum suggested cautious optimism among investors.

14 August 2026: Intraday High and Strong Outperformance Amid Market Weakness

Apollo Hospitals surged 3.46% intraday to a high of Rs.8,880, closing at Rs.8,925 with a 3.84% gain, significantly outperforming the Sensex’s 0.17% decline. The stock outpaced its hospital sector peers by 2.64%, reflecting strong buying interest and positive technical momentum.

Trading volume exploded to 318,240 shares, with a traded value of ₹22,628.67 lakhs, underscoring robust institutional participation. Despite trading within a narrow intraday range of Rs.8, the stock maintained gains for two consecutive sessions, accumulating a 3.53% return over this period.

Technically, the stock remained above its 5-day, 50-day, 100-day, and 200-day moving averages, signalling sustained medium- to long-term bullishness. Momentum indicators such as MACD and KST on weekly and monthly charts supported the positive outlook, although the Dow Theory suggested some short-term caution.

Key Takeaways from the Week

1. Elevated Derivatives Activity: The week saw multiple sharp increases in open interest, peaking at a 33.7% surge on 12 August, indicating active positioning and heightened volatility expectations among investors.

2. Mixed Price Performance: Despite strong derivatives interest, the stock declined early in the week, bottoming at Rs.8,565 on 12 August before recovering sharply on positive quarterly results and mojo upgrade.

3. Fundamental Strength: Record quarterly revenues and profits, margin expansion, and improved ROCE underpin the company’s robust operational performance and justify the upgraded Buy rating.

4. Institutional Confidence: Delivery volumes surged over 120% midweek, reflecting genuine accumulation and strong institutional participation supporting the stock’s recovery.

5. Technical Outlook: The stock’s position above key long-term moving averages and bullish momentum indicators suggest a cautiously optimistic medium-term outlook, though short-term resistance remains near the 52-week high.

Conclusion

Apollo Hospitals Enterprise Ltd. experienced a week of contrasting dynamics, with early price weakness offset by strong derivatives market activity and a robust fundamental backdrop. The company’s record quarterly results and mojo grade upgrade to Buy provided a catalyst for a late-week rally, culminating in a 3.84% gain on Friday and a close near Rs.8,925. While the stock underperformed the Sensex marginally over the week, the combination of elevated open interest, institutional buying, and positive technical signals suggests that investors remain engaged and optimistic about the company’s medium-term prospects. Monitoring the stock’s ability to sustain momentum above short-term moving averages and approach its 52-week high will be critical in assessing the durability of this recovery.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today